Xtx Topco LTD Precigen, Inc. Transaction History

Xtx Topco LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.89 - $1.41 $54,657 - $86,592	-61,413 Reduced 48.14%	66,162 $88,000
Q3 2023 Nov 13, 2023	SELL	$1.08 - $1.85 $146,308 - $250,621	-135,471 Reduced 51.5%	127,575 $181,000
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $145,604 - $212,339	-151,671 Reduced 36.57%	263,046 $302,000
Q1 2023 May 12, 2023	BUY	$0.88 - $2.19 $95,378 - $237,363	108,385 Added 35.38%	414,717 $439,000
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.26 $342,096 - $608,769	269,367 Added 728.71%	306,332 $465,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $50,665 - $100,253	-35,933 Reduced 49.29%	36,965 $78,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $2.53 $20,358 - $44,788	17,703 Added 32.07%	72,898 $98,000
Q1 2022 May 13, 2022	BUY	$1.91 - $3.98 $79,156 - $164,943	41,443 Added 301.36%	55,195 $116,000
Q4 2021 Feb 11, 2022	BUY	$3.53 - $5.5 $48,544 - $75,636	13,752 New	13,752 $51,000
Q2 2021 Aug 12, 2021	SELL	$6.24 - $8.22 $87,796 - $115,655	-14,070 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.74 - $10.95 $94,831 - $154,066	14,070 New	14,070 $97,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.